Fig. 3From: Response to chemotherapy combined with anlotinib plus anlotinib maintenance in intra-abdominal desmoplastic small round cell tumors (IADSRCT): a case report and literature reviewGrade 3 treatment-related adverse events. A Hematochezia after two cycles of the combined therapy. B Hematochezia disappeared after active managementBack to article page